Sound Income Strategies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-140
Closed -$30.4K 1090
2021
Q1
$30.4K Hold
140
0.01% 294
2020
Q4
$16K Hold
140
﹤0.01% 371
2020
Q3
$14K Hold
140
﹤0.01% 357
2020
Q2
$17K Hold
140
0.01% 303
2020
Q1
$12K Buy
140
+115
+460% +$12.2K ﹤0.01% 320
2019
Q4
$3K Hold
25
﹤0.01% 549
2019
Q3
$3K Hold
25
﹤0.01% 517
2019
Q2
$4K Hold
25
﹤0.01% 479
2019
Q1
$4K Hold
25
﹤0.01% 480
2018
Q4
$2K Buy
+25
New +$3.28K ﹤0.01% 561

Other funds holding GWPH

Sound Income Strategies's GWPH Position: Q2 2021 in Review

Sound Income Strategies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 140 shares — an estimated $30.4K sold.

Sound Income Strategies first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $30.4K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Sound Income Strategies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Sound Income Strategies sold 140 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $30.4K.
  • Sound Income Strategies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
  • Sound Income Strategies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $30.4K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Sound Income Strategies's 13F filing for Q2 2021, filed 13 Jul 2021.